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Abstract 
 The novel SARS-CoV-2 strain (COVID-19) was identified in Wuhan, China in December 
2019 (Eddy et. al, 2020). The resulting US outbreak has affected the Kaiser Permanente (KP) 
Oakland health care system. With the threat of COVID-19 highest among immunosuppressed 
and elderly clients, KP Oakland home health and hospice (HH/HO) department is rapidly 
mobilizing to provide community and in-home testing for eligible clients. A project was created 
to build a COVID-19 testing team workflow to provide diagnostic and preventative testing. This 
project focuses on team-based interventions that will change the pre-existing practice of 
requiring HH/HO clients to travel to remote testing sites or outpatient facilities for COVID-19 
specimen collection. COVID-19 sampling in a home environment reduces the risk of community 
spread and allows those who cannot travel to have the means to be tested (Kumari et. al, 2020).   
 The mitigation strategies for COVID-19 in the home environment must include specimen 
collection competencies, testing workflows, and creating case definitions for implementing 
testing practices. Per current national guidelines and KP mitigation strategies, clinical testing for 
COVID-19 is strongly recommended for symptomatic patients and required for asymptomatic 
patients receiving care in acute and outpatient procedural settings (see appendix A). 
 Outcome measures for this project include the number of HH/HO clients tested by the new 
KP Oakland testing team, compared to the number of HH/HO patients requiring testing at 
outside facilities or agencies.  The newly developed workflow also tracks the amount of days 








The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 
2020 (WHO, 2020). The incubation period of the COVID-19 is about 2 to 14 days and 
transmitted by respiratory droplets and close contact (Rahimzadeh et. al, 2020). Reported 
illnesses have ranged from mild to severe symptoms and, potentially, death. Significant 
symptoms include fever, cough, shortness of breath, pneumonia, and other respiratory tract 
involvement complications (Rahimzadeh et. al, 2020). Health care providers are managing 
patient symptoms using respiratory therapy, steroids, oxygen supplementation, and medications 
to expel mucus from the lungs. In severe cases, treatments to support organ function are 
necessary (Hamm, 2020).  
The community spread of COVID-19 has proved to be widespread and ongoing. Proper 
planning and preparedness is critical for maintaining healthcare services during the ongoing 
COVID-19 pandemic (CDC, 2020). As the healthcare system becomes increasingly complex and 
intertwined, different healthcare professionals are often required to work closely as part of an 
interprofessional healthcare team (Welsch et. al, 2018). It has been reported that effective 
teamwork and collaboration within healthcare teams improves the delivery of care and thus 
positively impacts patient outcomes (Welsch et. al, 2018). In response to a regional health crisis, 
education and leadership needs to be rapid and involve the multidisciplinary team working 
together to bridge practice gaps (Peterson et. al, 2020). 
This project aimed to decrease the number of clients tested remotely and increase the 
number of tests completed in the home environment.Prior to the integration of a COVID-19 
testing workflow, HH/HO clients that required testing were mainly routed to other agencies 
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outside of KP Oakland. The benchmark data on COVID-19 testing in May 2020, 3 clients were 
tested at remote testing centers, and 2 clients were tested in the home environment. Before 
introduction of this change project, the KP Oakland HH/HO testing rate was 66%, and the goal 
of this project was to provide 95% of all COVID-19 testing for HH/HO clients that meet the 
testing case definition.  
Providing quality specimen collection and testing procedure amid the global pandemic 
poses unique challenges, especially to the preexisting staff workflow for lab collection (Liebert, 
2020). Specific testing practices need to be put into place, including testing in the home 
environment for HH/HO clients, the use of personal protective equipment (PPE) and infection 
control practices for obtaining specimens (see Appendix B). The unique aspect of a HH/HO 
department is the variable environments for healthcare workers to provide care and treat clients. 
In a fragmented microsystem, it is key to streamline all diagnostic and procedural care to ensure 
that all healthcare workers are meeting agency competencies. Clients experiencing COVID-19 
symptoms should be tested early and efficiently to aide in developing a plan of care.   
Available Knowledge 
 The community resources and home care of KP Oakland’s HH/HO department are 
constantly being tested and improved. In the COVID-19 pandemic, it is crucial that the HH/HO 
department continually responds in a timely manner with home testing workflows, adequate PPE 
and testing resources and safe handling and transport of specimen to the laboratory. The PICO 
question (see Appendix C) for this change project revolves around the development of COVID-
19 testing protocols for the home environment. The outcome of this project is the improved 
testing workflow for HH/HO clients. In comparison, without a change project to create a testing 
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workflow, faulty or unsafe COVID-19 testing can negatively affect client outcomes and quality 
of life.  
 In HH/HO patients, quality COVID-19 testing by the established healthcare team directly 
increases patient health outcomes and satisfaction (WHO, 2020). By implementing home testing 
as safely and timely as possible, the hospice and home health clients can receive adequate 
epidemiological care, regardless of mobility and ability to travel.  
 Largely due to the variable protocols across Northern California and nationally, a 
preliminary literature review of COVID-19 testing procedures and workflows yielded mixed 
results. The search terms for the literature review included the key terms of “COVID-19 testing 
in the home environment” and “COVID-19 testing in a hospice facility”. The literature review 
was conducted using the database source CINAHL. A total of sixteen sources were reviewed and 
included in this paper. Included in the literature review were eleven sources from the United 
States, two from the United Kingdom, one from Singapore, one from Iran and one from India. 
The literature review included ten published evidence-based research articles, two excerpts from 
published textbooks, and four internet pages published by respected sources, including the World 
Health Organization (WHO) and the Center for Disease Control and Prevention (CDC).  
 A key component of this project was identifying the case definition for testing clients that 
receive services from the KP Oakland HH/HO department. It would be illogical and unnecessary 
to test every client on service; instead, a case definition must be developed to elucidate when 
testing is necessary. Implementing case definitions is an epidemiological requirement to 
standardize criteria for identification of cases (Pan American Health Organization, 1999). For the 
purposes of this project, an asymptomatic case refers to a client being tested for COVID-19 
without any symptoms or any known exposure. There are many reasons for an asymptomatic test 
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to be performed, including client transfer to a long-term care facility or an upcoming procedure 
that requires admittance to a hospital, other acute facility, or outpatient facility. A symptomatic 
case is a test ordered on a client exhibiting COVID-19 symptoms.  
Rationale 
 The rationale for this project was to standardize the practice of sample collection using a 
team-based approach for a population of HH/HO patients. Utilizing a framework that helps guide 
changes suggested by evidence-based literature, the ACE Star Model of Knowledge 
Transformation is well adapted not only to facilitate nursing change, but to better understand the 
knowledge behind that change (see Appendix D). Developed by faculty at the University of 
Texas, the model has five aspects, including discovery of knowledge, a summary of evidence, 
translating the evidence into clinical practice, integrating the recommended change into practice, 
and then evaluating the outcomes once the changes are incorporated (see Appendix D).  
 Using the ACE Star Model  (see Appendix D), the interventions are sustainable through the 
re-evaluation process, allowing for adjustment and continuous improvement. One aspect of the 
ACE Star Model that applies well to the HH/HO COVID-19 Community Testing Team is an 
ingrained understanding that clinical information and research is the basis for successful change 
process. The crucial step of knowledge transformation allows for the systematic organization of 
knowledge and application of knowledge opportunity. The ACE Star Model is a collaborative 
process that works well with other improvement methods, including the Model for Improvement 
(MFI). Advocated by the Institute for Healthcare Improvement (IHI), the MFI asked three simple 
questions: What are we trying to accomplish? How will we know the change is an improvement? 
What change can we make that will result in improvement? (Langley et al. 2009).  
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Specific Project Aim 
 Providing quality home health and hospice care amid the global pandemic poses unique 
challenges, especially related to COVID-19 testing procedures and staff workflow (Liebert, 
2020). Following both the CDC and the KP agency standards, a workflow was developed. As 
time progressed, and the pandemic has evolved, the expected outcomes remained the same for 
the purpose of this project. This change project was implemented to meet a specific aim:  
By August 05, 2020, the KP Oakland Home Health and Hospice department will provide 
95% of all COVID-19 testing for clients meeting both symptomatic and asymptomatic 
testing requirements, and will provide testing within 72 hours from physician order.  
Methods 
Context 
The IHI developed a Cultural Assessment Tool (see Appendix E) that enables 
organizations and agencies to determine the cultural environment through questions about safety, 
disclosure of adverse events, and client perception of care. Using this tool, an assessment of the 
microsystem was completed and revealed an environment ready and willing to incorporate 
change to the infection control and safety workflows. The staff already participate in ongoing 
training and continued learning, and a culture of safety is supported through just policies for 
reporting, safety protocols and a commitment to timely communication. 
In a HH/HO department, Strengths, Weaknesses, Opportunities and Threats (SWOT) 
analyses are completed to assess the organization’s current situation before deciding on a new 
strategy for change (see Appendix F). SWOTs provide healthcare leaders with a quick and 
simple overview of the microsystem and its processes. Moreover, SWOT analyses can provide 
high-quality information to stakeholders and personnel, and can demonstrate the microsystem’s 
COVID-19 TESTING TEAM 
8 
preparedness for upcoming threats (Ruffinen et. al, 2015). At the KP Oakland HH/HO 
department, the unique strengths include clear and efficient leadership over a highly specialized, 
sufficient amount of staff for testing. Also, the KP regional organization supports this program 
and there is considerable buy-in from the nursing staff, who want a safe and reliable way to test 
HH/HO clients.  
A fishbone diagram was created to delve into the various reasons for an increased need 
for a HH/HO COVID-19 testing workflow (see Appendix G). The fishbone diagram is a tool to 
determine various factors that contribute to a primary concern or problem in a microsystem. This 
change project revolves around testing processes, and therefore the fishbone reflects the different 
aspects that coalesced into a need for a community testing team and subsequent workflow. As 
many HH/HO clients are immobile and unable to travel to remote sites, key factors of the 
fishbone diagram include the high risk of contracting COVID-19 in the community outpatient 
setting and the increased risk of exposure from family.  
For this project, the KP Oakland HH/HO department has many resources available to 
assist the development and sustainability of new workflows. Return on investment (ROI) is a 
performance measure that calculates a company’s resultant cash flow after change is initiated. As 
this change project is implemented across the microsystem, the ROI was predetermined by 
regional HH/HO directors to be sufficient for the development and sustainability of the 
workflow. Per current CDC guidelines and agency mitigation strategies, PPE is supplied for 
every home health and hospice visit indefinitely. Face masks and face shields are a required for 
every home visit, regardless of the level of care provided. Masks cost approximately 0.6-1.9 
cents per mask depending on type, pricing, availability etc. Additionally, nurses completing 
COVID-19 testing wear gloves and don gowns for symptomatic tests. 
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Four nurses were trained to perform COVID-19 testing through a five-hour session 
completed on one day. The average HH/HO nurse salary at KP can range from $50-55. 
Approximate loss for the education session is $1,050 in wages, and does not include the cost for 
transportation and cost of collaboration with training personnel. Data collection, completed by a 
clinical nurse leader over a 25 week period, at $72/hour calculates out to $1,250 for data 
collection. No other initial start-up costs are evident. 
Interventions 
After identifying a need for testing among clients on service, the KP Oakland HH/HO 
department strategized how best to implement a COVID-19 testing workflow in late May of 
2020. Rolled out in June 2020, an internal workflow was initially developed through team 
collaboration. A specific number of registered nurses were selected to receive education on swab 
testing for COVID-19 and proper donning and doffing protocol of PPE. At this time, four nurses 
have received such education and achieved competency. The nurses were sent to observe and 
learn directly from the healthcare workers at the “drive-thru” testing sites set up by the regional 
Kaiser Permanente and located throughout Northern California. It took approximately 5 hours, in 
a one day period, to complete this training.  
After a physician’s order is acknowledged by the KP Oakland HH/HO department for a 
client’s COVID-19 test, the Quality Director notifies the interdisciplinary team of a potential 
symptomatic case vs asymptomatic case. One of the trained registered nurses is then assigned to 
this specific client’s case for the COVID-19 test. These visits are restricted to only obtaining the 
specimen for lab testing; the nurse is instructed to refrain from providing other care for the client 
due to the time constraints on the refrigerated specimen. The standard PPE for KP Oakland 
currently includes a face mask, face shield, and gloves, all of which is appropriate for an 
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asymptomatic test. After obtaining the specimen through proper swabbing technique, the nurse 
exits the client’s home whilst maintaining proper infection control protocols. The next step in 
this workflow is the lab, where the nurse must drop off the COVID-19 testing swab within one to 
two hours of collection. The specific location of the lab is pre-determined, based off of the 
distance and availability of the labs partnered with KP Oakland HH/HO. The nurse completes a 
warm hand-off with a laboratory supervisor for the test to be acknowledged.  
Clients that present with symptoms of COVID-19 and require a test from the KP Oakland 
HH/HO are classified as “patients under investigation” (PUI). A PUI mandates that the nurse 
follow stricter PPE requirements (i.e. gown) and an observer role to be present and available 
throughout the entire testing process. The observer role can be completed by physical therapists, 
occupational therapists, home health aide, or another registered nurse. All members of the 
interdisciplinary team meet competencies for proper donning and doffing procedure of PPE (see 
Appendix B). The observer remains outside the residence/testing environment for the procedure, 
and observes how the nurse dons and doffs PPE, handles the specimen, and helps with providing 
the proper insulated bag for the testing swab. This role is assigned for the swab test only, and the 
observer does not enter the home environment.  
 The last piece is the specific documentation for a COVID-19 test. Set forth by the larger 
regional KP agency, specific parameters for diligent documentation include the testing time, 
patient tolerance, lab information, and observer presence. At the KP Oakland HH/HO agency, 
the quality director monitors the tests and documentation, ensuring that the specimen arrived at 
the lab within the appropriate time frame and was received by the proper personnel. Once the lab 
results are known, the quality director follows up with the client’s healthcare team immediately 
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for both asymptomatic and symptomatic cases. In the occurrence of a positive, symptomatic 
client, the interdisciplinary team moves forward and identifies a care plan for the client. 
Measures 
A critical part of testing and implementing change is diligent and meaningful 
measurement that indicates improvement (“Science of Improvement”). For this change project, a 
balanced set of measures was used for all improvement efforts, including outcomes measures, 
process measures, and balancing measures (see Appendix H). The outcomes measures for this 
project include the number of patients tested by the KP Oakland HH/HO. According to the 
benchmark data obtained in May 2020, only 2 clients were able to be tested by healthcare 
providers through KP Oakland HH/HO, and 3 clients had to travel to remote testing centers. 
Translated into a percentage, KP Oakland HH/HO’s goal was to reach 95% of all COVID-19 
testing for clients that met case definitions. Process measures, which study if the change is 
performing as planned, include the days from order to testing date. The microsystem and testing 
team was given a goal of under 72 hours between the time of the test being ordered and the nurse 
performing the COVID-19 test in the home environment. This is a regionally-accepted 
timeframe, and was consistently met by both KP Oakland HH/HO and other remote testing sites 
prior to this new workflow introduction. Finally, balancing measures for this project are the 
patients identified by personnel for testing that do not meet the current case definition for 
specimen collection.  
Ethical Considerations 
The rare and special aspect of HH/HO care is the client’s supreme right to privacy; the 
client resides in their own environment, and spends large chunks of time free from healthcare 
professionals and support staff invading their space or territory (Scott et. al, 2003). In regards to 
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informational privacy, the client’s electronic health record is accessed through the testing nurse’s 
departmentally-issued laptop or tablet, and accesses the internet using a VPN. The process of 
data collection involves chart auditing and only tracks the total number of asymptomatic versus 
symptomatic cases. This data does not incorporate any protected health information. In regards 
to autonomy, COVID-19 testing is only completed on clients who consent to testing. Autonomy, 
or the ability to act according to one’s knowledge and judgment, is sustained through nursing 
care within existing professional, regulatory, and organizational rules. A self-assessment was 
completed to determine if this change project met ethical requirements. This project’s aim and 
methods do not come into conflict with commonly recognized values. Additionally, this project 
does not involve identifiable persons. No potential conflicts of interest were identified. 
Results 
Change projects require a timeline chart to identify when to approach goals and when to 
measure the change (see appendix I). A chart was developed after the onset of the COVID-19 
pandemic to help the microsystem’s leaders identify necessary steps for creating a testing 
workflow. The chart included dates for project conception, implementation and evaluation. The 
initial steps of the chart outline the time for project definition, aims and measures development, 
primary literature review, identification of changes to test, creation of the testing team and 
coordination of staff training. The project roll-out began on April 24, 2020. By May 8, 2020, 
workflows were developed through multiple interprofessional collaborative meetings; testers 
were trained and met competency standards for COVID-19 testing by May 15, 2020. A driver 
diagram was created to identify the order in which certain tasks needed to be implemented 
throughout the project timeline (see appendix J). Included in the driver diagram is the flow from 
the creation of the testing team into the wider tasks of education and creation of workflows.  
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Over the course of the project, various factors affecting the success of the change were 
identified and required new methods and adjustments. For example, the observer role was 
introduced after a need for an extra support staff during testing was identified. Additionally, a 
specific time frame for data collection had to be established to determine a clear point to stop and 
take an overview of the project and data. There were no unexpected costs associated with this 
project. Although much national and global attention around PPE shortages extended throughout 
this project, the regional KP organization mitigated such shortages appropriately and the 
microsystem never had to ration PPE.  
Benefits of this change project were identified through data review and tester feedback. 
Personal, informal interviewing of testers gave valuable insight to the testing process and aided 
workflow modifications and sustainability. The testers of the microsystem reported feeling safe 
and supported in the testing and specimen handling process. Reviewing charts and tracking cases 
is a continual process that ensures clients can be tested in an appropriate time frame.  
Discussion 
Summary 
 In March 2020, COVID-19 was declared a pandemic and was catapulted into a primary 
concern for healthcare agencies across the United States. KP Northern California mobilized 
quickly to develop new standards of practice for testing, specimen handling, data collection and 
organization of testing resources. In a home health and hospice population, invasive diagnostic 
procedures are not generally a standard for care; however, it became clear that developing a 
COVID-19 testing workflow was necessary after HH/HO clients required both symptomatic 
testing and asymptomatic testing by April and May of 2020.  
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 The key findings of this project indicate that the COVID-19 community testing team 
workflow is successful. A total of 26 symptomatic tests and 97 asymptomatic tests were 
performed by the KP Oakland HH/HO community testing team (see Appendix K). A combined 
total of 123 tests were performed between June 15, 2020 and September 28, 2020. This project 
far exceeded the projected goal of 75 completed COVID-19 tests (see Appendix H). A total of 
four clients were diverted for testing through other agencies; therefore, approximately 97% of 
HH/HO clients that met the case definition received testing through the KP Oakland community 
testing team. This exceeds the project charter goal of 95%. As this project surrounds workflow 
development and efficiency, a successful percentage of testing is key for the sustainability of this 
new testing team to continue through the COVID-19 pandemic.  
Conclusion 
COVID-19 diagnosis and treatment continues to be a challenging issue, as infection and 
mortality rates increase and cause significant expenditures on the United States healthcare 
system. Community spread of COVID-19 is projected to spike through November and December 
of 2020 and extend into the spring of 2021. This change project was developed during an integral 
period of the pandemic and need for COVID-19 testing will still be prevalent after the official 
end of this project. The developed workflow of testing for COVID-19 is sustainable for 
continuation and will be further led by quality improvement leaders and nursing staff in the 
microsystem. Implications for other microsystems and mesosystems include the potential for the 
workflows to become established practices in the regional KP departments of Northern 
California. Additionally, this project could be adapted for testing clients in long-stay acute 
rehabilitation centers, nursing homes and residential facilities.  
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Appendix E 
IHI Assessment Tool—A Culture of Respect, Communications, and Disclosure 
 Element** Y +- N 
Internal Culture 
of Safety 
The organization is grounded in the core values of compassion and respect and 
the ethical responsibility to always tell the truth to the patient and family. 
Y   
There is an expectation for ongoing communication, honesty, and transparency 
that is set from the board and leadership and closely monitored. 
Y   
Error is seen as the failure of systems and not people.   Y   
All can expect support at the sharp end of unanticipated outcome and near-miss. Y   
Malpractice  
Carrier 
There is a commitment to rapid disclosure and support. Y   
There is a written understanding of how cases will be managed in partnership 
between patient/family/carrier. 
Y   




There is a policy on patient and family communications. Y   
There is a policy on patient and family partnerships. 
Organizational infrastructure for clinician support exists. 
Y   
There are policies on disclosure and documentation. Y   
Procedures are known and in place for internal and external communication of 
sentinel events. 
Y   
Guidelines/policies support a fair and just culture (non-punitive) and the reporting 
of adverse events. 
Y   
There is a written crisis communication plan. This plan is centrally located and 
easily accessible by all staff. 
Y   
Training Ongoing training programs are in place for all staff on communication, 
expectations, policies, procedures, guidelines. 
Y   




There is rapid notification of patient/family and activation of support—typically 
immediately around what is known. 
Y   
There is a team to support staff preparing to disclose (coaches). Y   
Root cause analyses commence immediately, are closely managed, and the 
results are shared, including with the patient and family. 
Y   
The Disclosure The organization is transparent and honest. Y   
Responsibility is taken. Y   
We apologize/acknowledge. Y   
There is a commitment to providing follow-up information. Y   
The caregiver is supported throughout the process.   Y   
The organization provides continuing support for the patient/family. Y   
All hospital staff disclosing are trained in their role Y   
Ongoing Support Resources are available to assist families experiencing unanticipated outcomes 
(not limited to error) – support is defined by needs of the patient and family (e.g., 
emotional support). 
Y   
Resources are available to assist staff at the sharp end of unanticipated 
outcomes (not limited to error) – based on the needs of the clinician (e.g., 
emotional support). 
Y   
Procedures are in place and are known to ensure ongoing communications with 
patients, families, and staff. 
Y   
Resolution Procedures are in place and are known to bring the case to closure respectfully, 
as viewed by the patient and family. 
Y   
Learning  Mechanisms are in place to ensure learning by the board, executive leadership, 
MSEC, and across the organization. 
Y   
Measurement systems are in place to assess the impact of communication, 
disclosure, and support (as well as quality and safety) practices on premiums, 
claims, cases, and payments.   
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Appendix F 


































- Vague & disorganized national 
guidance on COVID-19 
guidelines and testing 
procedures 
- Potential shortages of 
PPE/swabs 




- Clear clinical leadership 
- Buy in from nursing staff  
- Nurses specialized in palliative 
and hospice care 
- Clear guidance from regional 
organization 
- Sufficient staff numbers for 
testings 
 
- Directly providing COVID-19 
resources to HH/HO clients 
- Inform clients early and reduce 
the risk of transmission through 
education 
- Reduction of inappropriate 
interventions/screenings 
- Allow clients to be tested 
without travelling 
- Potential for HH/HO personnel 
to contract and spread COVID-
19 
- Screenings may be seen as 
unnecessary by the family/client 
- Poor information processes 
means key prognostic 
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Appendix H 
IHI Science of Improvement: Family of Measures Assessment 
Measures, Outcomes, Processes and Balancing 
Measure Data Source  Target 
Outcome Measures   
# Home Health/Hospice patients 
tested by KP Community Testing 
Team 
KPHC Report 75 patients 
# patients requiring testing at test site 
or hospital 
Agency Spreadsheet 2 patients 
Process Measures   
Days from Order to Testing Date KPHC Report 72 hours from request to test  
Balancing Measures    
Patients ID’d who don’t require a test 
due to not meeting the current case 
definitions criteria 
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Appendix J 
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Appendix K 









Total Symptomatic Tests: 26 
Total Asymptomatic Tests: 97 
Total Tests Diverted through Other Agencies: 4 
 
